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ABSTRACT
Hyperoxia, is regularly introduced to critically ill patients in ICU. Nevertheless, recent
studies have shown the negative effects of this treatment on patients in critical care, including
increased rates of lung and cardiac injury and thereby high in-hospital mortality. Large part of the
literature related to hyperoxia was majorly focused on lung injury, with no or minimal
investigations on cardiac injury. Our lab is the first to investigate the effect of hyperoxia on cardiac
pathophysiology in mice and showed that mice exposed to hyperoxia for 3 days demonstrated
brady-arrhythmia, cardiac hypertrophy, QTc prolongation along with other electrical remodeling
and functional abnormalities due to dysregulation of important ion channels and other genes.
Although, rodents are widely used animal model for research studies, guinea pigs are well known
for its close similarity with human physiology. Therefore, to bring more clinical relevance to this
study, we have utilized guinea pigs and investigated effect of hyperoxia on cardiac remodeling.
For this study we exposed male guinea pigs (n=12) of one-year old age to hyperoxia or normoxia
for three days and investigated physical and electrical parameters. Similar to our previous reports
in mice, hyperoxia treated guinea pigs also showed significant reduction in body weight compared
to normoxia controls. We also observed lung edema in hyperoxia treated guinea pigs, as evident
by lung wet weight to dry weight ratio. Surprisingly in guinea pigs there are no significant changes
in heart weight after hyperoxia treatment which is different from our previous studies in mice.
Whereas we observed significant differences in left ventricle (LV), right ventricle (RV) and
septum cardiomyocytes size in hyperoxia treated hearts compared to normoxia control hearts. ECG
analysis revealed significant increase in RR intervals as a result of bradycardia, similar to what we
reported in mice. Whereas significant decrease in P duration, QTc interval, R amplitude and T
v

amplitude, which is distinct from what we observed in mice. From qRT-PCR data results we found
marginal difference in key ion channel Kv 1.4 and Kv 4.2 whereas in Kv 4.3 and Kv 2.1 showed
significant difference between normoxia and hyperoxia group which may be the reason of
arrythmias in hyperoxia guinea pigs. Overall, our data indicated that hyperoxia-induced cardiac
pathophysiology in guinea pigs are distinct from mice, despite of we similarities in physical
parameters.
The data obtained from this study will not only improve our understanding on hyperoxia
related in-hospital mortality, but also help us to understand possible mechanisms through which
hyperoxia induce cardiac pathophysiology. This will also open new avenues for targeted therapy

vi

CHAPTER ONE
INTRODUCTION

1.1 Hyperoxia Treatment on ICU Patients:
High oxygen O2 concentrations is mostly administered in the ICU patients to provide them
with physiological levels of oxygen and carbon dioxide. In different conditions like cardiac arrest,
stroke, respiratory failure, sepsis, Traumatic brain injuries (TBI) and after critical surgeries,
oxygen is provided with mechanical ventilation to the patients 1. Hyperoxia can be described as
administering a higher-than-normal concentration of O2 to lungs with mechanical ventilation.
Hyperoxemia indicates a high level of O2 in the bloodstream. In terms of pressure, the partial
pressure of O2 (PaO2) greater than 100 mm hg/13.3 kPa refers to a hyperoxic condition 2.
Despite its extensive practice of administering O2, a cohort study that evaluated arterial
hyperoxia in critically ill patients confirmed that there is a direct association between hyperoxia
and hospital mortality 3. Also, another study showed that hyperoxia tends to significantly change
cardiovascular and hemodynamic conditions which includes low cardiac output and stroke volume
4

. Adults who are treated with hyperoxic O2 reduces the cerebral blood flow by 11 to 33%.

Furthermore, we previously observed that the coronary artery blood flow decreases by 8-20%
when treated with normobaric hyperoxia in subjects with chronic heart failure and coronary artery
disease as well as in normal subjects 5. We demonstrated that there are significant marked ion
channel fluctuations and cardiac hypertrophy in mice when treated with extended hyperoxia, which
causes significant pathophysiological remodeling of the heart 6. Even though hyperoxia is used as
the primary treatment for patients with respiratory disorder, with this treatment there comes a
disadvantage that exposure to hyperoxia with longer duration (FIO2>0.8) can ultimately cause
1

hyperoxia-induced acute lung injury (HALI), which is a pathological condition characterized by
severe alveolar injury 7.
1.2 Hyperoxia and Lungs Pathophysiology:
It is estimated that in USA around 10000 to 15000 babies are born each year with
bronchopulmonary dysplasia (BPD) alone 8. Babies who are born prematurely with respiratory
distress syndrome recurrently go through bronchopulmonary dysplasia (BPD) which is
characterized by decreased coronary and alveolar development. Hyperoxia has a major role in back
regulation in the growth of vascular endothelial cells in the lungs. It is demonstrated that
interruptions in the regular growth and angiogenesis of capillaries with alveolar septa are a main
contributory feature in the exhibition and occurrence of BPD. Bhaskaran et al9 indicated that about
7 miRNAs are found to be altered in neonates when exposed to hyperoxia and the results indicated
that these miRNAs can be the key factors in controlling the pathogenesis of BPD. They
demonstrated that with hyperoxia the developing lungs induce p53 to produce miR-34a all over
the lungs which in turn attacks a wide variety of genes. These attacks tend to cause significant
changes to genes which alone or altogether trigger BPD pathway in neonates 9. Schematic diagram
of hyperoxia-induced ALI and BPD was illustrated in Figure 1.

2

Figure 1: Schematic chart of hyperoxia‐induced lung injury: Hyperoxia induce major lung
damage through mechanical injury, including biotrauma and volutrauma, which are collectively
called Ventilator‐Induced Lung Injury (VILI). Hyperoxia too actuates an incendiary response,
primarily through the generation of Responsive Oxygen Species (ROS). ROS generation is the
essential component of the improvement of Bronchopulmonary Dysplasia (BPD) and Acute
Lung Injury (ALI) [Color figure can be viewed at wileyonlinelibrary.com]10

1.3 Hyperoxia and Oxidative Stress:
Cells produce reactive oxygen species (ROS), by reducing the molecular oxygen (O2) to
water (H2O)

11

. These ROS facilitate normal lung pathophysiology within the body and are

produced when there is exposure to hyperoxic conditions. Prolonged hyperoxic exposure causes
an excess of ROS that disrupts the physiological balance between oxidants and antioxidants. This
elevation of ROS directly interrupts the physiological homeostasis causing injury to cells and body
tissues 12. Epithelial cells of the alveoli and related pulmonary capillaries are a potential target of
ROS. When targeted by ROS, the injury can lead to lung edema, fluid accumulation in alveoli,
deposition of collagen, hyaline, and elastin fibers in membranes, and hemorrhage of capillary
membranes

13

. At increased levels of oxygen, ROS devours all the endogenously produced
3

antioxidants enzymes henceforth causing cell death 14. Edema and inflammation of the lungs lining
are the most commonly reported harmful effects of hyperoxia, which is chiefly caused by the
elevation in the levels of ROS, which is directly associated with O2 levels in the lungs 15.
Various factors like atmospheric pressure, FIO2, duration of exposure and cumulative
oxygen dose determine and cause oxygen toxicity. When exposed to oxygen for a longer duration
i.e. (≥24 hours and FIO2 greater than (>0.60) at normal atmospheric pressure 1ATA (atmosphere
absolute), the oxygen becomes poisonous for the lungs. This kind of exposure is also called as
Lorraine smith effect, pulmonary toxicity, or low-pressure O2 toxicity 16. This oxygen toxicity also
occurs when exposure time to high FIO2 is small, but the ATA is increased i.e., 1.6-4, often known
as Paul Bert effect or high-pressure O2 poisoning. Such toxicity of oxygen has a lethal effect on
the central nervous system (CNS) 17. Conditions like congestion of lungs passageway, atelectasis,
and pulmonary edema are triggered by an injury to epithelial lining bronchi and alveoli which is a
consequence of prolonged exposure i.e., 12 hours to oxygen. This edema and fluid accumulation
of fluids in the lungs leads to symptoms like burning sensation in the chest and throat, shortness
of breath (SOB) and eventually turning the process of breathing painful for the subject

16

. With

Paul Bert's effect, CNS toxicity occurs which causes seizures in patients consequently leading to
coma within an hour i.e. (30-60 minutes) and can be potentially fatal to patients without any
warning sign. Other symptoms which are associated with CNS toxicity are disorientation, nausea,
and vomiting, touchiness, vision impairment, jerking of muscles, and giddiness

18

. Figure 2

illustrates schematic representation of summary of pathophysiological events induced during
pulmonary toxicity under hyperoxia exposure.

4

Figure 2: Summary of the pathophysiology of pulmonary oxygen toxicity 19

The production of free radicals is also a potential pathway that contributes towards the
pathophysiology of the lungs as the result of hyperoxia. Free radicals are known as reactive, very
short-lived, and unstable chemical particles. These chemical entities are called free as they have
possessed one or more unpaired electrons which are ready to react with chemical molecules in the
environment 12, 20.

5

1.4 Hyperoxia and Heart Pathophysiology:
Hyperoxia has been associated with causing noteworthy changes in the hemodynamics
which includes a decrease in cardiac output, heart rate, and stroke volume

21

. Study from our

laboratory demonstrated that hyperoxia (>90% oxygen) contributes significantly towards various
cardiac dysfunctions like hypertrophy and arrhythmias 6. Furthermore, vasoconstriction and
increase microcirculatory heterogeneity is caused by exposure to hyperoxia, henceforth
compromising perfusion 22. Vasoconstriction of coronary vessels is associated with a reduction in
oxygen delivery heart muscles and amplifies the vulnerability towards ischemia, as well as
decreases contractility of cardiac muscles 23.
Multiple research studies have demonstrated that hyperoxia is associated with cardiac
complications and has a direct impact on blood vessels. The rise in ROS adversely affects the
smooth muscle cells in the vessels by agonistic action of L-type Ca

++

channels and closing the

ATP-dependent potassium channels 23 24. ROS also affects the vascular tone in multiple ways i.e.,
decreasing prostacyclin, nitric oxide, and rising endothelin-1 levels 25. Various complication like
hypertension, cardiac parasympathetic induction and baroreflex function of Cardiovascular system
arises simply because of vasoconstriction. This also contributes towards decreased stroke volume
and heart rate 26.

6

Figure 3: Schematic chart of hyperoxia-induced cardiac pathophysiology. Hyperoxia
actuates cardiotoxicity by means of the production of serum cardiac markers cardiac troponin
I (cTnI) and lactate dehydrogenase (LDH). Hyperoxia too actuates inflammatory cytokines
through NFkB and cardiac hypertrophy through acceptance of MHC6 and 7. Test models from
our lab illustrate that hyperoxia induces critical Kv channel dysregulation through
downregulation of Kv4.2, Kv1.5, and KChIP2, which comes about in repolarization absconds
in mice, counting expanded activity potential lengths (APDs), QTc prolongation, arrhythmias,
and diminished heart rates. Experimental results in diabetic mice moreover illustrate that Kv
channel dysregulation and electrical remodeling may be a pre‐existing condition in these mice,
which has been connected to mir‐301a upregulation. Thus, diabetes in mice increases electrical
remodeling and Kv channel dysregulation due to hyperoxia presentation, as appeared by our
experimental comes about. MHC6: myosin overwhelming chain 6 [Color figure can be viewed
at wileyonlinelibrary.com] 10

Multiple research studies have demonstrated that hyperoxia is associated with cardiac
complications and has a direct impact on blood vessels. The rise in ROS adversely affects the
smooth muscle cells in the vessels by agonistic action of L-type Ca

++

channels and closing the

ATP-dependent potassium channels 23 24. ROS also affects the vascular tone in multiple ways i.e.,
7

decreasing prostacyclin, nitric oxide, and rising endothelin-1 levels 25. Various complication like
hypertension, cardiac parasympathetic induction and baroreflex function of Cardiovascular system
arises simply because of vasoconstriction. This also contributes towards decreased stroke volume
and heart rate 26.
In a study conducted by Spoelstra et al., Hyperoxia may directly cause a negative inotropic
effect on the heart. ROS can encourage the release of intracellular Ca++ by causing an alteration in
the Sarcoplasmic reticular and sarcolemmal release mechanism of Ca++. This overload in the Ca++
levels can lead to contractile dysfunction and ultimately cause cell death 27. Injury due to ischemia
and reperfusion to cardiac muscle and amplification in myocardial stunning is also associated with
hyperoxia 28. We previously demonstrated that hyperoxia activates the MHC6 and MHC7 which
in turn releases the inflammatory cytokines inducing NFkB and metabolic anomalies. It was
established that severe abnormalities occur in the Kv channels of rodents by Kv1.5, Kv4.5, and
KChIP2 which cause conformations anomalies and alters the duration of action potentials as well
6

. Also, another study demonstrated hyperoxia-induced ion channel remodeling in which there are

abnormalities in electrophysiological and mechanical function in heart failure. This dysfunction is
related to a rise in the expression of Kv1.4 and downfall in the levels of Kv4.5

6, 29

. We showed

that critical decrease in Kv4.2 expression just as protein articulation happens concerning hyperoxic
conditions 6. An investigational trial of diabetic mice suggested that Kv channels abnormality and
electromechanical renovation have become an issue in such mice that had been identified with
mir-301a upregulation

30

. Some of the events of hyperoxia-induced cardiac remodeling were

illustrated in Figure 3.
The poisoning of ROS mostly damages DNA, causes oxidation of proteins and lipids. The
oxidation of lipids of the intra and extracellular membranes causes inhibition of mitochondrial
8

energy cascade, oxidation of thiols, and deactivation of enzymes 31. Various defenses are prepared
by the body to mitigate the impact of ROS by preventing, repairing the affected tissue. These
defenses include enzymes (glutathione peroxidase, superoxide dismutase, and Catalase) and
nonenzymatic entities like Glutathione, Vitamin A and E, and Albumin 32. . ROS are proved to be
closely associated with hyperoxia as Oxygen is the main key factor for the production of ROS and
this cause upshift in the ROS levels, causing imbalance to oxidation and antioxidant balance which
in turn leads to inflammatory conditions like cardiac arrest 33. It is proved by various studies that
hyperoxia directly increases vascular resistance and inversely affects the heart rate 34.
1.5 Impact of Hyperoxia on the Whole Body:
For the normal physiological function of the body and cell, an appropriate amount of
oxygen is required. Also, low levels of oxygen saturation are life-threatening, especially in critical
circumstances. For such hypoxic conditions, supplemental oxygen is provided so that
physiological cell function and metabolism can be supported and avoid organ damage to the
maximum extent. However, patients who are suffering from hypoxia if given supplemental oxygen
will upsurge oxygen levels to the hyperoxemic range 18, 35. Normally, humans are often subjected
to hypoxic conditions like lung diseases or high altitude but administering supplemental oxygen
or hyperoxic condition is something that can be termed as a non-physiological event 36.
When subjected to hyperoxia multiple organs are affected throughout the body. This
hyperoxic state tends to increase the ROS which can directly injure different tissues when ROS
levels exceed the antioxidants 37. In a study, Orbegozo Cortés et al. stated that when evaluated by
sublingual side-stream dark field (SDF) video-microscopy, there is a decrease in the capillary
perfusion when a normal subjected to normobaric

9

38

. It is also suggested by a study that the

induction of vasoconstriction is a protective response to protect cells from the injurious effects of
increased levels of PaO2 39, 40
1.6 Why Hyperoxia is Important:
It is a common practice to administer supplementary oxygen to patients who are suffering
from severe lungs or heart diseases so that the normal oxygen supply to peripheral tissue can be
ensured. When exposed 9to a very high concentration of O2 i.e., Z 50% for a longer duration, this
can lead towards HALI 7. There is an increase in the levels of free radicals of oxygen when a
patient is exposed to high PaO2 due to increase FIO2, this upsurge in the levels of free radicals is
associated with neuronal injury and cell death ultimately leading to apoptosis. Furthermore,
various studies have proven by functional neurological testing that when administered to hyperoxia
after ROSC, the extent of brain injury and mortality increases 41, 42. Furthermore, in a clinical trial
study, an ST elevation is observed in the patient with myocardial infarction and a greater risk of
recurrence of MI, arrhythmias and MI size after six months when compared hyperoxia treated
patients with non-hyperoxic, which indicated that increase PaO2 might cause more reperfusion
injury to heart muscles 43.
It has been observed in various studies that administration of a high level of O2 harmfully
affects the heart and lungs, which increases increase the inflammation and damage caused by
inflammation. The damaged lungs caused a change in the structure of surfactant proteins as well
44

. When described anatomically, the lung's epithelial lining is prone to inflammation, research has

indicated that the superficial layers suffer from oxidation and the number of antioxidants to protect
the cell lining decreases. Consequently, ROS induces multiple signals transduction pathways to
bring about the needed response which is an adaptation, repair of the damaged cell or oncosis,
necrosis or apoptosis of the affected cell 45.
10

1.7 The Relation Between Hyperoxia and Delirium in Elderly Patients After Cardiac
Surgery:
One of the occurred complications after heart surgery is delirium. According to a study it
can occur in up to 52% of cases 46. Lopez et al., demonstrated that after cardiac surgery when the
cerebral oxygen levels were measured, it is observed that when exposed to a longer duration of
hyperoxia during cardiopulmonary bypass, the occurrence of delirium in the patients in up to 30%
after surgery. Additionally, modification in local and systemic perfusions, plasma pH and cellular
metabolism also occurs, which tends to increase the oxidative stress henceforth enhancing the
chances of delirium after surgery in patients

47

. Similarly, hydrogen peroxide another chemical

specie that is produced by ischemic tissue also decrease the neuronal function and increase the
susceptibility of delirium in mice with high oxidative stress 48. Furthermore, some of the oxidative
damage is also caused during the surgery which is caused by more or less removal of ROS, free
radicals, and nitrogen species. These are the compounds that are produced intraoperatively and
also add to the oxygenation stress produced due to hyperoxia administered during ischemia and
reperfusion and hemolysis

49

. It was also stated in a study that the oxidative injury that occurs

during the common surgeries is closely related to injuries of the kidney, heart and also associated
brain injury and dysfunction after surgery 50.
In a study conducted by Kupiec et al., it is demonstrated that hyperoxia increases the
chances of delirium after cardiopulmonary bypass surgery, so limiting the hyperoxia below 6.6kPa
during cardiopulmonary bypass can be a potential way of avoiding and decreasing the risk of
postoperative delirium 51.

11

1.8 Cardiac Arrest and In-Hospital Mortality Due to Hyperoxia:
The negative impact of hyperoxia has been reported in various studies in patients with MI
which includes, decrease coronary blood flow, high vascular resistance and mortality 52. Hyperoxia
is directly associated with the mortality rate in severely ill patients, Stroke, traumatic brain damage,
cardiac failure resuscitated subjects and patients in ICU

53

. Also in some studies, it has been

observed that hyperoxia have an injurious effect on the patients who are severely ill and also the
hyperoxic conditions adversely affect the cardiac parameters like vascular resistance, output,
cerebral blood flow and functions of lungs 54, 55. In a study conducted by Bodetoft et al., it has been
observed that there is low cardiac productivity, coronary oxygen distribution and perfusion of the
left ventricle when subjected to hyperoxia as compared to healthy individuals

56

. It has been

reported by Kim et al. that there is a high 28-day in-hospital mortality rate in MI patients when
administered oxygen during the first day of admission as well as more chances of occurrence of
complications like liver dysfunction and coagulation 57. Also, the younger ICU patients who face
fewer comorbidities demonstrated greater hyperoxic events especially when they have shorter
FiO2. Even though there is no strong correlation found between mechanical hyperoxia and 7 days
in-hospital mortality but it surely increases the hyperoxic burden over the ICU patients 58. Lastly,
in a meta-analysis conducted by You et al., it is stated by arterial hyperoxia is directly related to
the mortality rate of severely ill patients. This relation was established between the patients
specially admitted to critical care units due to intracerebral hemorrhage, cardiac arrest and
ischemia stroke 59.

12

1.9 Current Objective:
To investigate effects of hyperoxia exposure on cardiac pathophysiology in male (aged or
older) guinea pig hearts animal model.
1.10 Long Term Objective:
We will also investigate the influence of gender on hyperoxia-induced cardiac remodeling
in these animal model.

13

CHAPTER TWO
MATERIALS AND METHODS
2.1 Materials:
2.1.1 Animals:
Guinea pigs of species Hartley Guinea Pigs (n=6 per group) of one-year old age and
weighed average 900-1000g with health status Bright Active and Responsive (BAR) purchased
from Charles River. The sex of these guinea pigs was retired male breeders. They were randomly
selected for either hyperoxia or normoxia study groups. All guinea pigs were allowed access to
both food and water ad libitum for the duration of this study and were maintained on a 12 h
light/dark cycle. Each experimental research protocol was approved by the Institutional Animal
Care and Use Committee at the University of South Florida (Tampa, FL), in accordance with the
US National Institutes of Health.
2.2 Methods:
2.2.1 Hyperoxia Exposure:
Guinea pigs were divided in two groups of six guinea pigs each randomly as normoxia and
hyperoxia group. For hyperoxia group, guinea pigs were treated with >90% oxygen (hyperoxia)
for 72h, in an airtight chamber (50*50*30 cm) as per our previous reports 60. The guinea pigs were
set in a fixed hermetically sealed chamber with ad libitum food and water in 12h light/dark cycle.
Animals were inspected for any discomfort after every 6h. An oxygen analyzer (Vascular
Technology, Chelmsford, MA) was used to monitor oxygen levels throughout the exposure period.
For normoxia guinea pigs were placed under normal air for 72h with unrestricted water and food
supply. Immediately after normoxia or hyperoxia treatment, body weights were recorded for all
the animal.
14

2.2.2 Electrocardiography (ECG):
Guinea pigs were anesthetized with 1–2% isoflurane, followed by insertion of surface
probes in lead-II configuration for the acquisition of electrocardiogram (ECG) as shown in Figure
4.

Figure 4: Difference between Lead I, Lead II and Lead III configuration of ECG traces
recording.
ECG traces were recorded in a stretch of 30 s each and at three intervals from each
animal. While collecting ECG, heart rate signals were analyzed using PowerLab system and
LabChart 7.2 software (AD instruments, UK). As isoflurane and hyperoxia treatments
significantly lower the heart rates, we tried to collect ECG traces from each group at a fixed heart
rate.

15

Figure 5: Example of starting and ending of Intervals for RR, PR, QRS and QT intervals.

As shown in the Figure 5, RR interval, representing the time elapsed between two
successive R waves on the electrocardiogram and is a function of intrinsic properties of the sinus
node as well as autonomic influences. The PR interval is the time from the onset of the P wave to
the start of the QRS complex. It reflects conduction through the AV node. The QRS complex
represents ventricular depolarization. Ventricular rate can be calculated by determining the time
interval between QRS complexes. A corrected JT interval (JTc) was derived simply by subtracting
the QRS duration from the QTc. All values were calculated in milliseconds, Intervals for RR, PR,
QRS, and JT were each measured, with QT intervals measured at the start of Q peak up to TP
baseline.

16

2.2.3 Euthanization and collection of organs:
Soon after acquiring ECG recordings, animals were euthanized for thoracotomy via
intraperitoneal injection (IP) of 50 mg/kg euthasol. We also administered heparin (Sigma-Aldrich,
MA) (500 IU/kg/10 ml) via intraperitoneal injection (IP). This was immediately followed by blood
collection, heart and lungs excision. Blood was centrifuged at 5500 rpm for 5 min to collect plasma
serum and frozen at -80 until further use.
2.2.4 Lung edema:
Lungs wet to dry ratio was measured. To measure the whole sum of lung edema, the guinea
pigs were dissected and the lung weight was measured instantly after its extraction (wet weight)
The lungs were at that point dried in an oven at 60°C for overnight and re-weighed as dry weight
to evaluate lung edema in hyperoxia and normoxia treated lungs. Body weights and heart weights
were compared in both hyperoxia and normoxia groups and normalized with corresponding tibia
lengths.
2.2.5 Heart Weights and dissection:
Each heart was weighed and then dissected to separate right and left ventricles, apex, atrium,
and septum and were stored at − 80 °C for subsequent analysis, including RNA and protein
analysis.
2.2.6 RNA Isolation:
Total RNA was extracted from the left ventricles of all experimental groups, including in
normoxia and hyperoxia guinea pig groups using miRCURY RNA isolation kit (Exiqon, Woburn,
MA) as detailed below.
1. Approximately, 35mg of left ventricle tissue was homogenized in tissue lysis buffer.

17

2. 1/10 volume of miRNA Homogenate additive to the cell was added to the tissue lysate and
mixed well by vortexing several times. Mixture was left on ice for 10 min.
3. A volume of Acid-Phenol: Chloroform that is equal to the lysate volume was added, before
addition of the miRNA Homogenate additive. Vortex for 30-60 sec to make it mix properly.
4. After that it was centrifuged for 5 min at maximum speed (10,000 x g) at room temperature
to separate the aqueous phases.
5. Then the interphase should be compact and to this 1.25 volumes of room temperature 100%
ethanol were added (supernatant collected).
6. Filter Cartridge was placed into one of the Collection Tubes supplied for each sample.
Mixture of lysate/ethanol was pipet onto the Filter Cartridge. For passing mixture through
the filter it was centrifuged for 15 sec at 10,000 rpm. Flow-through was discarded and
repeated until all the lysate/ethanol mixture was through the filter.
7. Collection tube was reused for washing steps. 700 µL miRNA wash solution 1 was applied
to the filter cartridge and centrifuged for 5 to 10 sec. Flow-through from the Collection
tube was discarded and filter cartridge was replaced into the same Collection Tube.
8. 500 µL wash solution 2/3 was applied and drawn through the Filter Cartridge as previously
done.
9. Repeated with a second 500 µL aliquote of Wash Solution 2/3. After discarding the flowthrough from the last wash, Filter Cartridge was replaced in the same Collection Tube
followed by spinning the assembly for 1 min to remove residual fluid from the Filter.
10. The Filter Cartridge was transferred into a fresh Collection Tube (provided with the kit).
50 µL of pre-heated (95ºC) nuclease-free water was applied to the center of the filter, and
cap was closed. For recovering of RNA, it was spined for 20 to 30 sec at maximum speed.
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Elute was collected (which contains RNA) and stored at -20ºC. RNA elution was repeated
in separate tubes.
11. The total RNA concentration for each test was measured by a NanoDrop
spectrophotometer, and RNA quality was decided by 18S/28S ribosomal peak intensity.
2.2.7 cDNA Preparation:
Components of cDNA Supermix are qScript cDNA Supermix (5x) (qScript cDNA
SuperMix 5X reaction buffer from Bio-Rad laboratories, containing optimized concentrations of
MgCl2, dNTPs (dATP, dCTP, dGTP, dTTP), recombinant RNase inhibitor protein, qScript reverse
transcriptase, random primers, oligo(dT) primer and stabilizers) 4 µL to make final concentration
1x. RNA template was variable (1µg to 10 pg total RNA). RNase/DNase-free water was also
variable to make total volume 20 µL. Procedures are as detailed below:
1. Components were placed on ice and mixed and then briefly centrifuged to collect
contents to the bottom of the tube before using.
2. Reagents were combined in 0.2-mL micro-tubes.
3. After sealing each reaction, it was gently vortexed to mix contents. Then briefly
centrifuged to collect components at the bottom of the room reaction tube.
4. Centrifuged tubes were incubated for 5 minutes at 25ºC, 30 minutes at 42ºC, 5 minutes
at 85ºC and hold at 4ºC.
5. After completion of cDNA synthesis, 1/5th to 1/10th of the first-strand reaction (2-4)
was used for PCR amplification. cDNA samples were stored in -20 ºC until further use.
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2.2.8 qRT-PCR:
Real-time RT-PCR reaction was set-up using iQTM SYBER® Green supermix (2x
concentrated) ready to use reaction master mix optimized for dye-based quantitative PCR (qPCR).
It is consisting of antibody-mediated hot-start iTaq DNA polymerase, dNTPs, MgCl2, SYBER®
Green I dye, enhancers, stabilizers, and fluorescein.
1. iQTM SYBER® supermix and other frozen reaction components were thawed to room
temperature.
2. They were mixed thoroughly, centrifuged briefly to collect solutions at the bottom of
tubes, and then stored on ice protected from light.
3. Enough assay master mix for all reactions were prepared by adding all required
components, except the DNA template. iQTM SYBER® Green supermix (2x) diluted to
(1x) and 5 µL of it is taken.
4. Forward and reverse primer were used in 100 nM each (see Table 1. for sequence

information) and were in 0.25 µL quantity each. In DNA template cDNA was taken
1:10 ratio was in total 4.5 µL quantity making total quantity of all the components to
10 µL.
5. Assay of the master mix was mixed thoroughly to ensure homogeneity and dispensed
equal aliquots into each qPCR tube. Good pipetting practice was employed to ensure
assay precision and accuracy.
6. DNA samples were added to the PCR tubes containing assay master mix, tubes were
sealed to remove any air bubbles and the reaction mixture was collected in the vessel
bottom.
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7. Thermal cycling protocol on the real-time PCR instrument was programmed with initial
step of 50ºC for 5 minutes followed by denaturation at 95º for 10 sec, primer annealing
and extension at 60ºC for 30 sec for 39 cycles followed by melting curve cycle settings.
8. Afterwards, PCR tubes were loaded onto the real-time PCR instrument and run was
started.
9. Data analysis was performed according to the instrument-specific instructions. Cq
values for each sample from the iQ Cycler and fold values were collected. There were
two main parts in collecting these values, first was through the 7300 system SDS
software and secondly analysis through Excel. Steps are detailed below:
Table 1: List of Forward and Reverse Primer Sequence

KV2.1
KV2.2
KV4.2
Kv1.4
Kv4.3
KvLQT1
minK
ERG1
GAPDH
( Housekeeping gene)

FORWARD
CTCCACCATTGCCCTGTC
TCCCAGGAACAGATGAGC

REVERSE
TCCGCTTGATTGCTTTCTC
GAGTGGTGAGCGGAAAGT

CTTCACTATCCCCGCCAT
AACAGTCACATGCCTTATG
GAAGAGGAGCACATGGGC
GTTTGCCACATCAGCCATCA
GGGGACAGTTCAACCCAGTA
TGGCTCATCCTACTGCTGG

GTTTCCACCACATTCGCG
TAGTAAAACCTTCCCTCCTC
GTGATCTGGGATGTTTTGC
GGGACCTTGTCGCCGTAA
TTCAATGACGCAACACGAT
GGCTGACCACTTCCTCGTT

GCGCCGAGTATGTAGTGGAA

TGATTCACGCCCATCACGAA

∆Ct, and ∆∆Ct calculations:
a. For normalization, the relative quantities, or absolute quantities of the housekeeping gene
for all the samples were done once and used across all different primers for the same
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samples. Sometimes, the PCR data will have a very bad standard curve. Even in this case,
the data will have threshold cycle values (Ct values) for all samples. If there is a good
standard curve obtained for the same cDNA in the previous run, the Ct values of each sample
from the current run can be used to calculate the relative quantities from the previous
standard graph using an equation given below the graph.
b. Generate average Ct values by calculating averages for the duplicates and triplicates of
each normalizing gene and sample.
c. Calculate ∆Ct. ∆Ct = average Ct (sample) – average Ct (normalizing gene)
Note: Deltas are taken of the corresponding averages (average Ct of sample corresponding
to average Ct of normalizing gene)
d. Take the average of all ∆Cts to obtain final average.
e. ∆∆Ct = Ct (sample or normalizing gene…can you make sure? I think its sample) - ∆Ct (final average from part d)
f. To get the corresponding fold change for each sample calculate 2∆∆Ct (sample)
2.2.9 Immunohistochemistry:
Immunohistochemistry (IHC) is the foremost common application of immunostaining. It
includes the method of specifically distinguishing antigens (proteins) in cells of a tissue segment
by exploiting the rule of antibodies binding particularly to antigens in organic tissues.
2.2.9.1 Cryostat section:
1. Tissue was freeze up to 2.0 cm in diameter in OCT using a suitable tissue mold.
2. OCT was freeze with tissue onto the metal grids fitting the cryostat. At room
temperature, OCT is viscous but freezes at -20⁰C.
3. Sections were cut approximately 10 µm in the cryostat at the -20ºC.
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4. To evaluate the preservation and orientation of the tissue, the first slide of each set
can be stained using toluidine blue, eosin, hematoxylin, or various aqueous stain.
Slide was immediately immersed into a fixative.
2.2.9.2 H&E Staining:
To evaluate total cross-sectional area of each heart, we performed H&E staining. Active
ingredients for H&E staining include, 100% alcohol, 95% alcohol, Rapid-Fixx, Gill 3
Hematoxylin, Bluing reagent, Eosin-Y, Xylene and Shandon mounting medium.
The cryostat sections on the slides were kept on hot plates at 45ºC for 15 min. Sections were
washed with 1xTPBS for 3 times to remove OCT from the slides. Staining procedures were
performed as described below:
1. Rapid-Fixx was applied for 5-7 seconds, then distilled water was poured.
2. Hematoxylin was applied for 30 sec and again distilled water was poured on sample.
3. Sample was rinsed with few drops of Bluing reagent with the help of pipet and then rinsed
a little by 95% alcohol.
4. Eosin-Y was applied to the sample for 10 sec.
5. Sample was rinsed a little by 95% alcohol followed by a small amount of 100% alcohol
two times. In the end sample was rinsed twice by Xylene and frozen section was H&E
stained.
6. Slides were let over-night to completely dry mounting the slides with coverslip using
floromount medium (Fisher Scientific, USA).
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2.2.9.3 WGA Staining:
To measure individual cardiomyocyte area, we performed wheat germ agglutinin staining using
following protocol:
1. The 10-µm-thick frozen heart segments were settled with 4% PFA for 15 min. then washed
with PBS three times.
2. The heart segments were then incubated with WGA (L4895; Sigma-Aldrich) solubilized
in PBS for 20 min. at room temperature in darkness.
3. After washed three times with PBS, the segments were mounted with Prolong Gold
containing DAPI (P36941; Invitrogen) and kept at 4°C in darkness.
4. The Keyence BZ-X800 fluorescent microscope was utilized to obtain cardiomyocyte
measurements. A total of 20 fields per segment (80 LV, 40 RV, 20 Septum for each
specimen) were observed at 40x amplification and analyzed with ImageJ computer
program (National Organizing of Health). The cardiomyocyte area was measured by using
the freehand selection tool to outline the areas of the delineated cardiomyocytes.

2.2.10 Statistical Analysis:
All the samples were labeled with unique numbers and codes to make sure we have done
the analysis in blind fashion. For example hyperoxia and normoxia guinea pigs animal’s heart and
lungs samples numbering and codes were given to them randomly by mentor and student who is
analyzing the data was not aware of these numbering and coding so that he don’t know the
treatment of each sample he is analyzing to avoid biased interpretation of treatment. After
acquiring all the data then mentor revealed the identity and the analysis was done with the proper
grouping.
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All the experiments such as qRT-PCR and immunohistology were repeated at least three
times with animal triplicates and internal duplicates. All the mean (± SEM) values were expressed
in bar diagram and student t‐tests was utilized to evaluate significance (p-values). The information
analysis was utilized to compare the quantitative data populations of both typical dispersion and
equal variance, where a value of p ≤ 0.05 was considered statistically significant. The error
represent means ± SEM for all information sets.
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CHAPTER THREE
RESULTS
3.1 Physical Parameters:
Based on our previous experiments in mice6, hyperoxia significantly changed the physical
parameters such as body weight, heart weight and size, area of cross section of cardiomyocytes,
and lung (wet weight/dry weight). Therefore, we investigated if some of these physical parameters
are affected by the hyperoxia in the guinea pigs.
3.1.1 Body Weight:

Figure 6: Body weight normalized to tibia length (g/cm), percentage weight loss.
Figure demonstrates significant reduction in the body weight of Guinea Pigs who were exposed
to hyperoxia for 72 hours. All the data presented here are mean of (±SEM) n = 6, ***p ≤ 0.0005.

From our data, we found out that after 72h of hyperoxia treatment, the body weight of
guinea pigs was significantly reduced by 8.135 %. (Figure 6) as compared to the normoxia treated
guinea pigs. From this it is evident that hyperoxia treatment significantly diminished body weights
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(normalized to tibia length). All the values presented in the bar are mean (±SE) of n=6. ***
represents p-value ≤0.0005 compared to normoxia control.
3.1.2 Heart Size and Weight of Hyperoxia/Normoxia Treated Guinea Pigs:

B

A

Figure 7: Physical parameters of heart. In (A) it is comparison of two physical hearts of
normoxia and hyperoxia treated Guinea Pigs, to see the size difference between both of them.
There was no size difference found. (B) shows the comparison between weight of normoxia
treated group vs hyperoxia treated group, also there was no significant difference was found in
both groups. All the values presented in the bar are mean (±SE) of n=6.

As we observed significant change in body weights in hyperoxia treated group, we also
measured heart size and heart weight to see if there is any hypertrophy in heart after treatment with
hyperoxia. Surprisingly, no significant changes in heart size (Figure 7A) and weight (Figure 7B)
were observed after hyperoxia treatment. Even though there was no change in the heart size and
shape, we measured the area of cross section of the entire hearts as well as each cardiomyocyte.
H&E staining was used to measure the area of cross section of entire hearts (Figure 8A) and WGA
staining was used to measure size of cardiomyocytes.
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3.1.3 Wheat germ agglutinin (WGA) Staining of cardiomyocytes:

Figure 8 (A): Comparative image of H&E staining of total cross sectional area of heart of
both normoxia and hyperoxia guinea pig. Total area of cross section is decreasing after
hyperoxia treatment.
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Figure 8 (B): Wheat germ agglutinin (WGA) image comparison of normoxia and hyperoxia
LV, RV and septum.: From images it is evident that LV cardiomyocytes in guinea pigs are
decreasing while RV and Septum are increasing in size after hyperoxia treatment as compared
to normoxia controls.
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Figure 8 (C): Wheat germ agglutinin (WGA) Staining revealed significant changes in
cardiomyocyte size after hyperoxia treatment. Area of cross section of Cardiomyocytes from
normoxia and hyperoxia LV (a), RV (b), Septum (c) and all pooled data (d). All the values
presented in the bar are mean (±SE) of n=6. *** represents p-value ≤0.0005 compared to
normoxia control.

From our data, it is evident that as shown in Figure 8 (B&C) from WGA staining, after
hyperoxia treatment in older guinea pigs (Figure 8C_a) LV cardiomyocyte size is significantly
decreasing while (Figure 8C_b) RV and (Figure 8C_c) septum cardiomyocyte sizes are
significantly increased. Whereas, when we combine all (Figure 8C_d) LV, RV and septum data,
cardiomyocyte size overall in hyperoxia hearts are significantly smaller than normoxia
cardiomyocytes. All the values presented in the bar are mean (±SE) of n=2. *** represents p-value
≤0.0005 compared to normoxia controls.
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3.1.4 Lungs wet/dry Weight ratio:

Figure 9: Physical parameters of lungs wet to dry ratio upon hyperoxia exposure. All the
values presented in the bar are mean (±SE) of n=6. *** represents p-value ≤0.0005 compared
to normoxia control.
Hyperoxia is known to induce lung edema due to accumulation of lung fluids 14. We also
examined that if 72h of hyperoxia treatment in older guinea pigs cause lung edema similar to the
previous reports in mice. Briefly, confined lungs weighed to get wet weight and dried up overnight
at 130 °C in a vacuum oven. Dry lung weights were at that point recorded and the proportion of
the wet to dry weights was calculated. Our data showed that older guinea pigs treated with 72h of
hyperoxia had significant lung edema which is evident by significantly higher wet/dry weight ratio
in hyperoxia treated lungs compared to normoxia controls as shown in Figure 9. All the values
presented in the bar are mean (±SE) of n=6. *** represents p-value ≤0.0005 compared to normoxia
control.
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3.2 Electrophysiological Parameters:
Electrocardiogram:

A

B

Figure 10: Schematic Electrical impairment and arrhythmias in hyperoxia treated Guinea
Pig hearts. Brady‐arrhythmia and repolarization defects were shown upon hyperoxia exposure
in Guinea Pig: (A) Representative ECG (electrocardiogram) of Guinea Pig in normal air
environment. (B) represents recordings from hyperoxia treated Guinea Pig having.

We took ECG recordings of normaxia group of guinea pigs before euthanization and organ
collection and also of the hyperoxia group of guinea pigs right after hyperoxia treatment. Surface
ECG was collected in lead-II mode under mild anesthesia and data was analyzed using LabChart
Pro software as described in our previous studies
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. We observed arrhythmias characterized by

missed beats and slower heart rate in hyperoxia treated older guinea pigs when compared with agematched normoxia (Figure 10).
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Figure 11 (A, B, C, D and E): Guinea pigs showed prolonged RR intervals (A) because of
brady-cardia similar to what we reported in mice. Surprisingly, shorter QTc (B) intervals with
no significant change in (C) PR, (D) QRS and (E) JT interval were observed in guinea pigs
under hyperoxia. All the values presented in the bar are mean (±SE) of n=6. *** represents pvalue ≤0.0005 compared to normoxia control.
Further evaluation of electrocardiogram parameters revealed significant changes in RR interval
(Figure 11A) and QTc intervals (Figure 11B) in hyperoxia treated guinea pigs. We observed
significant increase in the RR interval indicating a decrease in heart rate (brady-cardia) among the
hyperoxia treated older guinea pigs similar to what we reported in mice. Interestingly, we observed
significant reduction of QTc intervals in the hyperoxic treated older guinea pigs compared to agematched normoxia controls (Figure 11B). Additionally, there were no significant changes in the
PR, QRS, and JT intervals (Figure 11 C to E) in the hyperoxic treated older guinea pigs compared
to age-matched normoxia controls.
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3.3 Real-time RT-PCR:
As we observed arrhythmias and repolarization defects in hyperoxia treated guinea pigs,
we investigated if these electrophysiological changes are due to dysregulation of key ion channel
genes such as potassium channel genes. For that we utilized quantitative real-time RT-PCR
analysis. Although we didn’t find any significant differences in gene expression of key ion
channels like Kv2.2, ERG and KvLQ as shown in Table 2, which were known to express in guinea
pig hearts

62, 63

, we found marginal difference in Kv1.4 and Kv4.2 and significant difference in

Kv4.3 and Kv2.1 in hyperoxia treated guinea pig hearts.

Table 2: Real-Time RT-PCR analysis of potassium channel genes

Gene
Kv1.4
Kv4.2
Kv4.3
Kv2.2
Kv2.1
ERG
KvLQ

Normoxia
1.32 (±0.42)
1.10 (±0.32)
1.44 (±0.5)
2.10 (±1.01)
1.21 (±0.35)
1.80 (±0.67)
1.44 (±0.70)

Mean (±SE)
Hyperoxia
6.1 (±2.2)ϯ
53 (±22.8)ϯ
3.3 (±0.5)*
1.2 (±2.3)
2.5 (±0.3)ϯ
2.3 (±0.1)
2.2 (±0.6)ϯ

Note: Ϯ represents marginal differences and * shows significant differences.
3.4 Mortality:
The hyperoxic treatment also led to the death of Guinea pigs. The mortality rate of was
found to be 50% which means 3/6 Guinea pigs died of the hyperoxic treatment, which is considered
to be very high mortality rate.
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CHAPTER FOUR
DISCUSSION

Mechanical ventilation is often related with greater in‐hospital death rate 64, with long‐term
utilize being for the most part related with destitute survival rates in ICU patients 65. Previously in
our lab we have done a significant amount of work on effects of hyperoxia in rodents and now for
the first time we are presenting our data in relatively bigger animal (Guinea Pigs) to bring more
translational value to our studies as guinea pigs are known to be closer to human compared to
rodents. Our lab already illustrated that adult male C57BL/6J wild‐type mice showed significant
LV hypertrophy, arrhythmias, QTc and JT prolongation, and potassium channel dysregulation, as
a result of 72 h hyperoxia exposure 6. Although aged guinea pigs have a lot of similarities with
young mice data after hyperoxia treatment, we also observed some distinct physiological features
in older guinea pigs under hyperoxia compared to mice. Surface ECG evaluation showed
essentially slower heart rate (sinus bradycardia) and skipped beats (sinus delay) in all the hyperoxia
treated guinea pigs compared to normoxia group, demonstrating cardiac arrhythmia (Figure 10).
It is conceivable that changed parasympathetic and/or sympathetic tone may intercede these
changes as both autonomic nervous system components direct heart rate and rhythm 66.
QT interval is the time from the end of the Q wave at ECG to the end of the T wave. QTc
is the interval corrected for the heart rate. It comprises the QRS complex, the ST segment, and the
T wave and it is a measure of ventricular repolarization. Alterations in QTc interval results into
certain arrhythmias depending upon whether the interval is prolonged or shortened. In previous
experiments with mice, we were the first to demonstrate that the QTc prolongation was seen in the
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hyperoxia treated mice which was validated by qrt-PCR downregulation of Kv 4.2 and Kv 1.5 6.
Here, with guinea pigs, we observed Qtc shortening in the hyperoxia treatment group which was
further validated by the qrt-PCR results showing upregulation of the Kv 4.2 and Kv 2.1 ion
channels. In humans it has been shown that hypoxic treatments such as climbing high altitudes
resulted into prolongation of QTc interval 67. Therefore, it is plausible that shortening of the QT
interval by hyperoxia treatment is due to upregulation of the Kv 4.2 and and 2.1 in guinea pigs
which results into bradyarrhythmia and skipped heartbeat. Hence it signifies the
pathophysiological effect of hyperoxia in guinea pigs.
The heart is exceedingly delicate to oxygen
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, and hyperoxia treated rodent hearts

experience systemic hypoxia due to accumulation of lung liquid69. It is likely that this may reduce
cellular oxygenation, tissue digestion system and lead to hoisted redox stress as watched through
altered pyridine nucleotide levels. The increase in the sum of decreased pyridine nucleotides
(NADH, NADPH) in the cell causes reductive push70. Diminished body mass and expanded or
decreased heart mass are the commonly observed physical changes with hyperoxia presentation,
as showed in our past research 6, 60, 71, and in the current study (Figure 6 & 8). Although we did
not degree the nourishment admissions, diminished cellular energy supply may be a likely donor
of body weight misfortune, as concomitant enteral sustenance weakens hyperoxia initiated weight
loss in animal models, expanded heart weight in hyperoxia‐treated mice results primarily from left
ventricular hypertrophy (LVH), through increased expressions of MHC‐6/MHC-7 6. LVH has too
been appeared to create in young mice after neonatal hyperoxia presentation

72

. Whereas, aged

guinea pigs, unlike mice, don't exhibit cardiac hypertrophy, as a result of hyperoxia. Furthermore,
these observations observed in male guinea pigs were comparable to female mice data, which have
been appeared to be ensured from cardiac hypertrophy, possibly due to estrogen cardio-protective
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nature 73. In future we will expand our research in female guinea pigs and see if they show any
cardiac hypertrophy with hyperoxia treatment. Although we cannot report a clear component for
higher mortality in male guinea pigs test subjects in this research, we observed 50% mortality in
hyperoxia‐treated guinea pigs. If we compare this mortality rate with our previous studies in
rodents, we found no mortality rate in male mice, but in female mice the mortality rate was exactly
same 50%60.
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CHAPTER FIVE
CONCLUSION
Guinea pigs showed distinct physiological features under hyperoxia compared to mice
(rodents). Although guinea pigs lose body weights under hyperoxia, no significant change in heart
size or weight. Whereas we observed significant decrease in cardiomyocyte size in hyperoxia
treated hearts compared to normoxia. ECG analysis revealed brady-cardia in guinea pigs after
hyperoxia, but with shortened QTc intervals with no significant change in PR, QRS, and JT
intervals. Evaluation of mRNA expression profiles of some key ion channel genes reveal upregulation of Kv4.3 and 2.1 in hyperoxia treated mice hearts, which may be partly inducing
arrhythmias and QTc shortening in guinea pigs. Further investigation on hyperoxia-induced
electrical remodeling using more precise and specific techniques may give more insights on
cardiac pathophysiology under these conditions. Although, we observed some similarities between
mice and guinea pigs, hyperoxia exposed guinea pigs showed some distinct features. The data
obtained from this study will not only improve our understanding on hyperoxia related in-hospital
mortality but will also help us to understand possible mechanisms through which hyperoxia induce
cardiac pathophysiology conditions. In addition, it will open new avenues for targeted therapy. As
guinea pigs are closer to human than rodent, data obtained from this study will bring more
translational value to our hyperoxia experiments. Our research offers novel insights into the
cardiotoxicity and resulted electrophysiological consequences caused by introduction to high
levels of oxygen.
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